Cooper Investors, an investment management firm, released its “Cooper Investors Global Equities Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned 6.24% in the fourth quarter, compared to a 7.08% return for the benchmark MSCI ACWI. For the year 2022, the fund returned -24.69% compared to a -17.71% return for its benchmark. In addition, please check the fund’s top five holdings to know its best picks in 2022.
Cooper Investors highlighted stocks like Haleon plc (NYSE:HLN) in the fourth quarter 2022 investor letter. Headquartered in Brentford, the United Kingdom, Haleon plc (NYSE:HLN) is a consumer healthcare products company. On January 18, 2023, Haleon plc (NYSE:HLN) stock closed at $7.91 per share. One-month return of Haleon plc (NYSE:HLN) was 0.13%, and year to date its shares lost 1.13% of their value. Haleon plc (NYSE:HLN) has a market capitalization of $36.523 billion.
Cooper Investors made the following comment about Haleon plc (NYSE:HLN) in its Q4 2022 investor letter:
“Haleon plc (NYSE:HLN) is one of the largest consumer healthcare businesses in the world, selling non-prescription products that address a therapeutic need like Sensodyne toothpaste, Panadol, Advil, Voltaren pain relief, and Centrum vitamins. Haleon’s portfolio of household brands are time-tested and have significant scale advantages in marketing, research and development and distribution. In this category having trusted relationships with healthcare professionals like dentists and pharmacists is critical – Haleon has one of the largest networks of relationships globally. Next time you get sick in a far-flung tropical country on holiday, chances are Panadol will be available in the local drugstore.
While Haleon’s brands have been around for many decades, Haleon the company is relatively young, the result of a long[1]planned combination of the consumer health portfolios of Novartis, GlaxoSmithKline (GSK) and Pfizer. It was created through various transactions and asset swaps and the final form was spun-off on the UK exchange from GSK just 6 months ago. We have been tracking the progress of this story and meeting the executives involved for several years, waiting for this spin-off…” (Click here to read the full text)
Image by my best in collections – see and press 👍🔖 from Pixabay
Haleon plc (NYSE:HLN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held Haleon plc (NYSE:HLN) at the end of the third quarter, which was 0 in the previous quarter.
We discussed Haleon plc (NYSE:HLN) in another article and shared Ariel Investments’ views on the company. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
- 12 Biggest Ocean Cleaning Companies in the World
- 15 Biggest Window Manufacturing Companies
- 25 Countries that Have the Most Debt Per Capita
Disclosure: None. This article is originally published at Insider Monkey.
